Articles
29.03.2021
What is Relative Effectiveness Assessment

Relative Effectiveness Assessment (REA) is a type of assessment that evaluates the effectiveness of ...

Read more
Articles
15.03.2021
Identifying market access challenges

Interactive eLearning is a fantastic way of engaging with small to large scale audiences that can be...

Read more
News
11.03.2021
Asia Pacific Digital Health Insights

Remap Consulting recently attended an ISPOR webinar discussing the digital health ecosystem in APAC ...

Read more
Articles
01.03.2021
NRDL expansions

China has the second largest healthcare system in the world. However, this market has been challengi...

Read more
Articles
11.02.2021
EMA Human Medicines

Last month, EMA published its overview of key recommendations for 2020 on the authorisation and safe...

Read more
Articles
26.01.2021
Improving access to innovative medicine in the UK

Following Brexit, the Medicines and Healthcare Regularoty Agency (MHRA) has become the UK's sole bod...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more
Publications
19.11.2020
ISPO 2020 Developing a sustainable biosimilar

To facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosim...

Read more
Publications
19.11.2020
COVID-19 impact on HTA bodies

HTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...

Read more
Publications
19.11.2020
ISPOR 2020 New NICE STA process

This study aimed to assess whether the new process has resulted in changes to outcomes of STAs.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.